Notícias Eulerpool Santhera Pharmaceuticals Holding

Santhera Pharmaceuticals Holding Eulerpool-AFX

Santhera Pharmaceuticals Holding Notícias de ações

Santhera Pharmaceuticals Holding é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Santhera Pharmaceuticals Holding nós reunimos aqui.

• 10 de junho ·

  Yahoo
  Santhera Announces Launch of Early Access Program in China for AGAMREE® by its Partner Sperogenix
• 28 de maio ·

  Yahoo
  Santhera Publishes Agenda for its Annual General Meeting
• 28 de maio ·

  Yahoo
  Santhera Publishes Annual Report 2023
• 25 de abril ·

  Yahoo
  Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May
• 31 de março ·

  SeekingAlpha
  Week In Review: AriBio Sells China Rights To Alzheimer's Candidate In $770M Deal
• 27 de março ·

  Yahoo
  Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted and Granted Priority Review by China’s NMPA
• 14 de março ·

  Yahoo
  Santhera’s Partner Catalyst Pharmaceuticals Launches AGAMREE® (Vamorolone) in the United States
• 14 de fevereiro ·

  Yahoo
  Santhera Announces Publication of Efficacy, Safety and Tolerability Data with Vamorolone (AGAMREE®) in Patients with Duchenne Muscular Dystrophy in Neurology
• 15 de janeiro ·

  Yahoo
  Santhera Launches AGAMREE® (Vamorolone) in Germany as First Market for the Treatment of Duchenne Muscular Dystrophy
• 12 de janeiro ·

  Yahoo
  Santhera Receives Approval for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy in the United Kingdom